1.65

1.85% 0.03

Immutep Limited Adr (IMMP)

Überblick Nachrichten Preisverlauf Optionskette Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

$1.62

Offen:

$1.64

24-Stunden-Volumen:

181.86K

Relative Volume:

2.16

Marktkapitalisierung:

$242.20M

Einnahmen:

Nettoeinkommen (Verlust:

KGV:

-7.3431

EPS:

-0.2247

Netto-Cashflow:

1W Leistung:

+2.48%

1M Leistung:

-7.30%

6M Leistung:

-7.82%

1J Leistung:

-35.80%

1-Tages-Spanne:

$1.5912

$1.67

1-Wochen-Bereich:

$1.59

$1.68

52-Wochen-Spanne:

$1.32

$2.72

Immutep Limited Adr Stock (IMMP) Company Profile

Firmenname

Immutep Limited Adr

Sektor

Healthcare (1149)

Branche

Biotechnology (644)

Telefon

Adresse

Mitarbeiter

Twitter

Nächster Verdiensttermin

2025-08-29

Neueste SEC-Einreichungen

IMMP's Discussions on Twitter

Vergleichen Sie IMMP mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
IMMP Immutep Limited Adr	1.65	237.79M	0	0	0	0.00
VRTX Vertex Pharmaceuticals Inc	396.12	101.77B	11.39B	3.64B	3.50B	13.99
REGN Regeneron Pharmaceuticals Inc	573.38	60.12B	14.21B	4.46B	3.56B	39.68
ALNY Alnylam Pharmaceuticals Inc	452.00	59.45B	2.46B	-319.09M	-52.09M	-2.47
ARGX Argen X Se Adr	750.78	44.90B	3.06B	1.28B	447.35M	21.30
ONC Beone Medicines Ltd Adr	341.80	35.07B	3.81B	-644.79M	-669.77M	-6.24

Immutep Limited Adr Stock (IMMP) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-05-17	Eingeleitet	CapitalOne	Overweight
2023-08-03	Eingeleitet	Robert W. Baird	Outperform
2021-08-03	Eingeleitet	Ladenburg Thalmann	Buy
2021-07-16	Fortgesetzt	Maxim Group	Buy
2018-09-28	Eingeleitet	B. Riley FBR	Buy
2018-02-15	Bestätigt	Maxim Group	Buy

Alle ansehen

Immutep Limited Adr Aktie (IMMP) Neueste Nachrichten

Sep 04, 2025

Immutep Limited Depositary Receipt Stock Lags Behind Sector BenchmarksMarket Performance Report & Weekly Setup with High ROI Potential - beatles.ru

Sep 04, 2025

Aug 17, 2025

Immutep Limited (IMMP) Receives Positive FDA Feedback on Future Clinical Development of Eftilagimod Alfa - Yahoo Finance

Aug 17, 2025

Aug 16, 2025

12 Best Australian Stocks to Buy Right Now - Insider Monkey

Aug 16, 2025

Aug 04, 2025

Immutep Gains FDA Support for Cancer Therapy Development - TipRanks

Aug 04, 2025

Jul 25, 2025

Is Immutep Limited Depositary Receipt a good long term investmentFree Stock Market Return Analysis - PrintWeekIndia

Jul 25, 2025

Jul 19, 2025

Immutep Limited Depositary Receipt Stock Analysis and ForecastExceptional gains - jammulinksnews.com

Jul 19, 2025

Jun 15, 2025

Millennium Management LLC Sells 19,242 Shares of Immutep Limited (NASDAQ:IMMP) - Defense World

Jun 15, 2025

Jun 08, 2025

Jane Street Group LLC Has $98,000 Position in Immutep Limited (NASDAQ:IMMP) - Defense World

Jun 08, 2025

Jun 01, 2025

Immutep Ltd Highlights Immune System Innovations at Healthcare Conference - TipRanks

Jun 01, 2025

May 08, 2025

Market Highlights: Immutep Limited ADR (IMMP) Ends on a Low Note at 1.93 - DWinneX

May 08, 2025

May 06, 2025

Immutep stock soars on promising trial results By Investing.com - Investing.com Australia

May 06, 2025

May 05, 2025

Immutep Limited (ASX:IMM) Initiates Phase III Trial for Non-Small Cell Lung Cancer - thecapitalclub.com.au

Mar 24, 2025

Feb 11, 2025

Is Immutep Limited (IMMP) the Best Long Term ASX Stock to Buy Now? - AInvest

Feb 11, 2025

Dec 17, 2024

Immutep Announces Initial Safety Data from First-in-Human Phase I Trial Evaluating IMP761 - GlobeNewswire

Dec 17, 2024

Jun 27, 2024

Baird cuts Immutep stock target on phase 2b trial results, retains Outperform - Investing.com

Jun 27, 2024

Apr 18, 2024

Immutep appoints research institute to conduct first-in-human study of IMP761 - Biotech Dispatch

Apr 18, 2024

Feb 05, 2024

10 Best Australian Stocks To Buy - Yahoo Finance

Feb 05, 2024

Nov 27, 2023